Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
EXCLUSIVE: Worksport Ropes In Digital BD to Probe Short Selling, CEO Buys Stock At Premium (UPDATED)
Today 8:14 EST
From Benzinga
From Benzinga
From Benzinga
Asia And Europe Markets Mixed; Dollar Hovers Near 52-Week High - Global Markets Today While US Slept
Today 6:40 EST
From Benzinga
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
November 20, 2024
From Benzinga
From Benzinga
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
The Trade Desk Launches Ventura to Transform Streaming TV Advertising
November 20, 2024
From Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
November 20, 2024
From Benzinga
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
From Benzinga
WeRide's Robotaxi And Partnerships Are Key Growth Drivers For Global Expansion: Analyst
November 20, 2024
From Benzinga
What's Going On With C3.ai Stock Wednesday?
November 20, 2024
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
Mullen Lands Big Wins With California Universities: Details
November 20, 2024
From Benzinga
From Benzinga
What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?
November 20, 2024
From Benzinga
Palantir Tech's $140 Billion Market Cap Gain Is Driven By Trump's Victory And Higher Defense Spending Hope - Is The Stock Overvalued?
November 20, 2024
From Benzinga
From Benzinga
Global-E Soars: Q3 Sales Surge 32%, FY24 Outlook Raised Amid GMV Boom
November 20, 2024
From Benzinga
What's Going On With GlobalFoundries Stock Today?
November 20, 2024
From Benzinga
Salesforce Tool Aims To Simplify AI Agent Testing, Deployment
November 20, 2024
From Benzinga
From Benzinga
After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
November 20, 2024
From Benzinga
What's Going On With XPeng Stock Today?
November 20, 2024
From Benzinga
From Benzinga
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
November 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.